115 related articles for article (PubMed ID: 18646325)
1. A new procedure for the quantitative assessment of p-glycoprotein efflux pump associated with human T lymphocytes.
Vélez R; Sánchez Mdel C; Lopez P; Yamamura Y
Ethn Dis; 2008; 18(2 Suppl 2):S2-75-80. PubMed ID: 18646325
[TBL] [Abstract][Full Text] [Related]
2. Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging.
Pilarski LM; Paine D; McElhaney JE; Cass CE; Belch AR
Am J Hematol; 1995 Aug; 49(4):323-35. PubMed ID: 7639278
[TBL] [Abstract][Full Text] [Related]
3. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
Parasrampuria DA; Lantz MV; Benet LZ
Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
[TBL] [Abstract][Full Text] [Related]
4. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging.
Vilas-Boas V; Silva R; Gaio AR; Martins AM; Lima SC; Cordeiro-da-Silva A; de Lourdes Bastos M; Remião F
Cytometry A; 2011 Nov; 79(11):912-9. PubMed ID: 21905209
[TBL] [Abstract][Full Text] [Related]
6. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
[TBL] [Abstract][Full Text] [Related]
7. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
Pilarski LM; Belch AR
Blood; 1994 Feb; 83(3):724-36. PubMed ID: 7507731
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.
Chaudhary PM; Mechetner EB; Roninson IB
Blood; 1992 Dec; 80(11):2735-9. PubMed ID: 1360267
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes.
Farrell RJ; Menconi MJ; Keates AC; Kelly CP
Aliment Pharmacol Ther; 2002 May; 16(5):1021-31. PubMed ID: 11966513
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients.
Donnenberg VS; Burckart GJ; Griffith BP; Jain AB; Zeevi A; Berg AD
J Clin Pharmacol; 2001 Dec; 41(12):1271-9. PubMed ID: 11762554
[TBL] [Abstract][Full Text] [Related]
12. Is rhodamine 123 an appropriate fluorescent probe to assess P-glycoprotein mediated multidrug resistance in vinblastine-resistant CHO cells?
Pétriz J; O'Connor JE; Carmona M; García-López J
Anal Cell Pathol; 1997; 14(3):129-40. PubMed ID: 9354229
[TBL] [Abstract][Full Text] [Related]
13. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
14. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Lucia MB; Rutella S; Leone G; Vella S; Cauda R
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
[TBL] [Abstract][Full Text] [Related]
15. Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.
Shiraki N; Hamada A; Ohmura T; Tokunaga J; Oyama N; Nakano M
Biol Pharm Bull; 2001 May; 24(5):555-7. PubMed ID: 11379779
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes.
Yacyshyn BR; Bowen-Yacyshyn MB; Pilarski LM
Scand J Immunol; 1996 Apr; 43(4):449-55. PubMed ID: 8668925
[TBL] [Abstract][Full Text] [Related]
17. Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry.
Maynadié M; Matutes E; Catovsky D
Leuk Res; 1997 Sep; 21(9):825-31. PubMed ID: 9393597
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
[TBL] [Abstract][Full Text] [Related]
20. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.
Drach J; Gsur A; Hamilton G; Zhao S; Angerler J; Fiegl M; Zojer N; Raderer M; Haberl I; Andreeff M; Huber H
Blood; 1996 Sep; 88(5):1747-54. PubMed ID: 8781431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]